Bates, P. C., R. Aston, and A. T. Holder. Growth hormone control of tissue protein metabolism in dwarf mice: enhancement by a monoclonal antibody. J. Endocrinol. 132: 369-375, 1992.
Baxter, R. C., and J. L. Martin. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J. Clin. Invest. 78: 1504-1512, 1986.
Bick, T., Z. Hochberg, T. Amit, O. Isaksson, and J. O. Jansson. Roles of pulsatility and continuity of growth hormone (GH) administration in the regulation of hepatic GH receptors, and circulating GH-binding protein and insulin-like growth factor-I. Endocrinology 131: 423-429, 1992.
Blum, W. F., M. B. Ranke, K. Kietzmann, E. Gauggel, H. J. Zeisel, and J. R. Bierich. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J. Clin. Endocrinol. Metab. 70: 1292-1298, 1990.
Brown, M. B., and A. B. Forsythe. The small sample behaviour of some statistics which test the equality of several means. Technometrics 16: 129-132, 1974.
Chirgwin, J. M., A. E. Przybla, R. J. MacDonald, and W. J. Rutter. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18: 5294-5299, 1977.
Clark, R. G., D. Mortensen, D. Reifsynder, M. Molher, T. Etcheverry, and V. Mukku. Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth-promoting activities of rhIGF-I in the rats. Growth Regul. 3: 50-52, 1993.
Conover, C. A., and D. R. Powell. Insulin-like growth factor (IGF) binding protein-3 blocks IGF-I-induced receptor down-regulation and cell densitization in cultured bovine fibroblasts. Endocrinology 129: 710-716, 1991.
DeMellow, J. S. M., and R. C. Baxter. Growth hormone dependent insulin-like growth factor binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in skin fibroblats. Biochem. Biophys. Res. Commun. 156: 199-204, 1988.
Ernst, M., and G. A. Rodan. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127: 807-814, 1990.
Fleiss, J. L. The Design and Analysis of Clinical Experiments. New York: Wiley, 1986.
Gray, R. S., P. Cowan, U. di Mario, R. A. Elton, B. F. Clarke, and L. J. P. Ducan. Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics. Br. Med. J. 290: 1687-1691, 1985.
Hamon, G. A., T. K. Hunt, and E. M. Spencer. In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds. Growth Regul. 3: 53-56, 1993.
Hossenlopp, P., D. Seurin, B. Segovia-Quinson, S. Hardouin, and M. Binoux. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154: 138-143, 1986.
Jones, J. I., and D. R. Clemmons. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16: 3-34, 1994.
Maes, M., J. M. Ketelslegers, and L. E. Underwood. Low plasma somatomedin-C in streptozotocin-induced diabetes mellitus. Diabetes 32: 1060-1069, 1983.
Maiter, D., T. Fliesen, L. E. Underwood, M. Maes, G. Gerard, M. L. Davenport, and J. M. Ketelslegers. Dietary protein restriction decreases insulin-like growth factor I independent of insulin and liver growth hormone binding. Endocrinology 124 2604-2609, 1989.
Maiter, D., L. E. Underwood, M. Maes, M. L. Davenport, and J. M. Ketelslegers. Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats. Endocrinology 123: 1053-1059, 1988.
Maiter, D., L. E. Underwood, M. Maes, and J. M. Ketelslegers. Acute down-regulation of the somatogenic receptors in rat liver by a single injection of growth hormone. Endocrinology 122: 1291-1296, 1988.
Massart, S., D. Maiter, D. Portetelle, E. Adam, R. Renaville, and J. M. Ketelslegers. Monoclonal antibodies to bovine growth hormone potentiate hormonal activity in vivo by enhancing growth hormone binding to hepatic somatogenic receptors. J. Endocrinol. 139: 383-393, 1993.
Mazza, M., and L. A. Retegui. Monoclonal antibodies to human growth hormone induce an allosteric conformational change in the antigen. Immunology 67: 148-153, 1989.
McCusker, R. H., C. Camacho-Hubner, M. L. Bayne, M. A. Cascieri, and D. R. Clemmons. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs). J. Cell. Physiol. 144: 244-253, 1990.
Moats-Staats, B. M., J. L. Brady, L. E. Underwood, and A. J. D'Ercole. Dietary protein restriction in artificially reared neonatal rats causes a reduction of insulin-like growth factor-I gene expression. Endocrinology 125: 2368-2374, 1989.
Moller, J., J. Jorgensen, N. Moller, D. W. Hansen, E. B. Pedersen, and J. S. Christiansen. Expansion of extracellular volume and suspension of atrial natriuretic peptide after growth hormone administration in normal man. J. Clin. Endocrinol. Metab. 72: 768-772, 1991.
Pell, J. M., I. D. Johnsson, R. A. Pullar, D. J. Morrell, I. C. Hart, A. T. Holder, and R. Aston. Potentiation of growth hormone activity in sheep using monoclonal antibodies. J. Endocrinol. 120: R15-R18, 1989.
Roguin, L. P., R. C. Aguilar, and L. A. Retegui. Monoclonal antibodies to human growth hormone modulate its biological properties. Mol. Immunol. 32: 399-405, 1995.
Shimasaki, S., and N. Ling. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog. Growth Factor Res. 3: 243-266, 1991.
Tans, C., F. Dubois, Z. D. Zhong, M. Jadot, R. Wattiaux, and S. Wattiaux-De Coninck. Uptake by rat liver of bovine growth hormone free or bound to a monoclonal antibody. Biol. Cell 82: 45-49, 1994.
Thissen, J. P., J. B. Pucilowska, and L. E. Underwood. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF binding protein messenger ribonucleic acids by amino add availability and growth hormone in rat hepatocyte primary culture. Endocrinology 134: 1570-1576, 1994.
Thissen, J. P., S. Triest, B. M. Moats-Staats, L. E. Underwood, T. Mauerhoff, D. Maiter, and J. M. Ketelslegers. Evidence that pretranslational and translational defects decrease serum insulin-like growth factor-I concentrations during dietary protein restriction. Endocrinology 129: 429-435, 1991.
Wallis, M., M. Daniels, K. P. Ray, J. D. Cottingham, and R. Aston. Monoclonal antibodies to bovine growth hormone potentiate effects of the hormone on somatomedin-C levels and growth of hypophysectomized rats. Biochem. Biophys. Res. Commun. 149: 187-193, 1987.
Zapf, J., C. Hauri, M. Waldvogel, and E. R. Froesch. Acute metabolic effects and half-lives of intravenously administered insulin-like growth factor-I and II in normal and hypophysectomized rats. J. Clin. Invest. 77: 1768-1775, 1986.
Zapf, J., C. Hauri, M. Waldvogel, E. Futo, H. Häsler, K. Binz, H. P. Guler, C. Schmid, and E. R. Froesch. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc. Natl. Acad. Sci. USA 86: 3813-3817, 1989.
Zapf, J. Physiological role of the insulin-like growth factor binding proteins. Eur. J. Endocrinol. 132: 645-654, 1995.
